These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20558918)

  • 1. Antibiotic prophylaxis in transcatheter treatment of hepatocellular carcinoma: an open randomized prospective study of oral versus intravenous administration.
    Ebisutani C; Sato S; Nishi K; Inoue H; Yoshie T; Kinoshita Y
    Intern Med; 2010; 49(12):1059-65. PubMed ID: 20558918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic prophylaxis in transarterial chemoembolization of hepatocellular carcinoma.
    Mansour MA; Khalifa MO
    Arab J Gastroenterol; 2018 Mar; 19(1):16-20. PubMed ID: 29503075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial.
    Okusaka T; Kasugai H; Shioyama Y; Tanaka K; Kudo M; Saisho H; Osaki Y; Sata M; Fujiyama S; Kumada T; Sato K; Yamamoto S; Hinotsu S; Sato T
    J Hepatol; 2009 Dec; 51(6):1030-6. PubMed ID: 19864035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of procalcitonin in diagnosis of bacterial infection in trans-arterial chemoembolisation treated hepatocellular carcinoma patients.
    Dabbous HK; Ali-Eldin FA; Montasser IM
    Arab J Gastroenterol; 2015 Mar; 16(1):10-3. PubMed ID: 25865041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
    Mabed M; Esmaeel M; El-Khodary T; Awad M; Amer T
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):492-9. PubMed ID: 19453695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Necessity of prophylactic antibiotics in patients with primary liver cancer undergoing transcatheter arterial chemoembolization: a prospective study].
    Wang JY; Chen Y; Lu W; Wei CJ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):757-8. PubMed ID: 15958334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic prophylaxis and the clinical meaning after transcatheter treatment for hepatocellular carcinoma: indicated?
    Ishikawa T
    Intern Med; 2010; 49(12):1049-50. PubMed ID: 20558916
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
    Ueda H; Tanaka H; Kida Y; Fukuchi H; Ichinose M
    Oncol Rep; 2008 May; 19(5):1355-61. PubMed ID: 18425398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.
    Nishikawa H; Osaki Y; Kita R; Kimura T; Ohara Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Nishiguchi S
    Oncol Rep; 2014 Jan; 31(1):65-72. PubMed ID: 24220763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
    Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM; Qin H; Wang CB; Fang XH; Ma QY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of transcatheter arterial chemoembolization with miriplatin-lipiodol water-soluble contrast agent emulsion in patients with hepatocellular carcinoma.
    Okimoto K; Ogasawara S; Chiba T; Ooka Y; Oobu M; Azemoto R; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Yoshikawa M; Yokosuka O
    Anticancer Res; 2013 Dec; 33(12):5603-9. PubMed ID: 24324105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of endostatin combined with continuous transcatheter arterial infusion and chemoembolization on gastric cancer with liver metastasis and analysis of prognosis.
    Chen L; Shi H; Che Y; Sun W; Niu X; Lu W
    J BUON; 2020; 25(3):1469-1475. PubMed ID: 32862592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of postoperative antiviral combined transcatheter arterial chemoembolization therapy in prevention of hepatitis B-related hepatocellular carcinoma recurrence.
    Yan Q; Ni J; Zhang GL; Yao X; Yuan WB; Zhou L; Zheng SS
    Chin Med J (Engl); 2013 Mar; 126(5):855-9. PubMed ID: 23489790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Yamashita F; Tanaka M; Andou E; Yutani S; Kato O; Tanikawa K
    Oncology; 1997; 54(1):28-33. PubMed ID: 8978589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
    Lee HS; Kim KM; Yoon JH; Lee TR; Suh KS; Lee KU; Chung JW; Park JH; Kim CY
    J Clin Oncol; 2002 Nov; 20(22):4459-65. PubMed ID: 12431969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized prospective study of oral versus intravenous antibiotic prophylaxis against postoperative infection after sagittal split ramus osteotomy of the mandible.
    Yoda T; Sakai E; Harada K; Mori M; Sakamoto I; Enomoto S
    Chemotherapy; 2000; 46(6):438-44. PubMed ID: 11053909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
    Sahara S; Kawai N; Sato M; Tanaka T; Ikoma A; Nakata K; Sanda H; Minamiguchi H; Nakai M; Shirai S; Sonomura T
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1363-71. PubMed ID: 22358993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective Analysis of Chinese Patients with Hepatocellular Carcinoma (HCC) undergoing Transcatheter Arterial Chemoembolization (TACE) with or without Prophylactic Antibiotic Therapy.
    Chen J; Wu G
    J Coll Physicians Surg Pak; 2018 Dec; 28(12):914-918. PubMed ID: 30501826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical feasibility and safety of laparoscopic right hepatectomy for hepatocellular carcinoma following sequential TACE-PVE: a comparative study.
    Goumard C; Komatsu S; Brustia R; Fartoux L; Soubrane O; Scatton O
    Surg Endosc; 2017 May; 31(5):2340-2349. PubMed ID: 27655376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.